Semaglutide exerts significant modulating effects on intestinal microbiota

The article entitled ‘Effects of semaglutide on gut microbiota, cognitive function and inflammation in obese mice’ explores the impact of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, on gut microbiota composition, cognitive function and inflammation in obese mice fed a high-fat diet. Conducted by a team of researchers in China, this study aimed to understand how semaglutide could modulate the intestinal microbiota and thus attenuate the cognitive deficits and inflammation associated with obesity.